Eli Lilly

News

Lilly preps for rollout of its connected diabetes system

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies.

Events

Partner Content

6th Obesity & NASH Drug Development Summit 2022

Explore Holistic Approaches to Metabolic Syndrome

News

Planning appeal blocks Lilly's €400m plant in Ireland

Eli Lilly's plans for a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines, including its new Alzheimer's can

News

Lilly says Mounjaro launch is "viral in nature"

One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been

News

Lilly has committed $42.5 million over 10 years to fund pharmaceutical manufacturing scholarships for incoming Purdue undergraduate students, offering 75-100 talented students each year full tuition with a guaranteed internship (Purdue University photo)

Lilly deepens bonds with Purdue University with new funding ...

Eli Lilly's links to Purdue University go back a long way, and have been reinvigorated with $92.5 million in additional funding and renewed research collaborations.

News

Lilly nabs another gene therapy firm, buying hearing loss pl...

Eli Lilly has agreed to buy hearing loss gene therapy developer Akouos in a deal that could value the company at around $610 million – if its lead candidate progresses as hoped in the clini

Lilly preps for rollout of its connected diabetes system

6th Obesity & NASH Drug Development Summit 2022

Planning appeal blocks Lilly's €400m plant in Ireland

Lilly says Mounjaro launch is "viral in nature"

Lilly deepens bonds with Purdue University with new funding ...

Lilly nabs another gene therapy firm, buying hearing loss pl...

Biogen, Denali pull Parkinson's drug after failed trial

Discover a new era of healthcare panel engagement: Grounded ...

Eli Lilly

Editor's Picks